Supplementary Expression Data from Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or &lt;i&gt;BRCA&lt;/i&gt;-Mutant Ovarian Cancer